Liggins Institute, University of Auckland, Auckland 1142, New Zealand.
Department of Radiology, Auckland Radiology Group, Auckland 1050, New Zealand.
J Clin Endocrinol Metab. 2022 Nov 25;107(12):3252-3260. doi: 10.1210/clinem/dgac546.
Hysterosalpingography (HSG) with oil-soluble contrast medium (OSCM) improves pregnancy rates. However, OSCM has high iodine content and long half-life, leading to potential iodine excess.
This work aimed to determine the pattern of iodine excess after OSCM HSG and the effect on thyroid function.
A prospective cohort study was conducted of 196 consecutive consenting eligible women without overt hypothyroidism or hyperthyroidism. All completed the study with compliance greater than 95%. Participants underwent OSCM HSG (Auckland, 2019-2021) with serial monitoring of thyrotropin (TSH), free thyroxine (FT4), and urine iodine concentration (UIC) for 24 weeks. The main outcome measure was the development of subclinical hypothyroidism (SCH), defined as a nonpregnant TSH greater than 4 mIU/L with normal FT4 (11-22 pmol/L) in those with normal baseline thyroid function.
Iodine excess (UIC ≥ 300 μg/L) was almost universal (98%) with UIC peaking usually by 4 weeks. There was marked iodine excess, with 90% and 17% of participants having UIC greater than or equal to 1000 μg/L and greater than 10 000 μg/L, respectively. Iodine excess was prolonged with 67% having a UIC greater than or equal to 1000 μg/L for at least 3 months. SCH developed in 38%; the majority (96%) were mild (TSH 4-10 mIU/L) and most developed SCH by week 4 (75%). Three participants met the current treatment guidelines (TSH > 10 mIU/L). Thyroxine treatment of mild SCH tended to improve pregnancy success (P = .063). Hyperthyroidism (TSH < 0.3 mIU/L) occurred in 9 participants (5%).
OSCM HSG resulted in marked and prolonged iodine excess. SCH occurred frequently with late-onset hyperthyroidism occasionally. Regular thyroid function tests are required for 6 months following this procedure.
油溶性造影剂(OSCM)子宫输卵管造影(HSG)可提高妊娠率。然而,OSCM 碘含量高,半衰期长,导致潜在的碘过量。
本研究旨在确定 OSCM HSG 后碘过量的模式及其对甲状腺功能的影响。
对 196 名连续同意的无明显甲状腺功能减退或甲状腺功能亢进的合格女性进行前瞻性队列研究。所有参与者均完成了研究,依从性大于 95%。参与者接受 OSCM HSG(奥克兰,2019-2021 年),同时连续监测促甲状腺激素(TSH)、游离甲状腺素(FT4)和尿碘浓度(UIC)24 周。主要观察指标为亚临床甲状腺功能减退症(SCH)的发生,定义为非妊娠时 TSH 大于 4 mIU/L,同时基线甲状腺功能正常时 FT4 正常(11-22 pmol/L)。
碘过量(UIC≥300μg/L)几乎普遍存在(98%),UIC 通常在 4 周时达到峰值。碘过量明显,90%和 17%的参与者 UIC 分别大于或等于 1000μg/L 和大于 10000μg/L。碘过量持续时间长,67%的参与者 UIC 大于或等于 1000μg/L 至少持续 3 个月。38%发生 SCH,大多数(96%)为轻度(TSH 4-10 mIU/L),大多数在第 4 周时发生 SCH(75%)。3 名参与者符合当前治疗指南(TSH>10 mIU/L)。轻度 SCH 给予甲状腺素治疗,妊娠成功率有升高趋势(P=0.063)。9 名参与者(5%)发生甲状腺功能亢进症(TSH<0.3 mIU/L)。
OSCM HSG 导致明显且持续的碘过量。SCH 常发生,迟发性甲状腺功能亢进症偶有发生。该操作后需定期进行 6 个月的甲状腺功能检查。